Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Mancini (Vancouver, British Columbia, Canada). COPD coronary/peripheral vascular disease. Research Seminar 2006 - Complexity of patients with multiple chronic diseases

Member's Comments

No comment yet.

Related content which might interest you: Determinants of success Source: Eur Respir J 2011; 38: 1215-1218 Year: 2011 Physical activity practice reduces risk of admission for a COPD exacerbation in COPD from a prospective population based study Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 How patients cope with exacerbations in primary care: the COPD health study Source: Annual Congress 2006 - Exacerbation of COPD Year: 2006 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Assessing the multivariate structure and influence of comorbidity in COPD Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 The DOSE index predicts quality of life, healthcare consumption and mortality Source: Annual Congress 2007 - Predicting factors of patients undergoing rehabilitation Year: 2007 Socioeconomic risk factors for COPD and respiratory symptoms in a general population Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 The relationship between depression, medication and stage of the disease in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006 Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 COPD prevalence is increased in lung cancer, independent of age, sex and smoking history Source: Eur Respir J 2009; 33: 380-386 Year: 2009 Mortality in COPD: role of comorbidities Source: Eur Respir J 2006; 28: 1245-1257 Year: 2006 Developing COPD – a 25 year follow-up study of the general population Source: Annual Congress 2005 - Better understanding of lung function decline and COPD Year: 2005 Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 COPD-related morbidity and mortality after smoking cessation: status of the evidence Source: Eur Respir J 2008; 32: 844-853 Year: 2008 Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project Source: Eur Respir J 2012; 39: 1343-1353 Year: 2012 Epidemiology of COPD Source: Eur Respir Rev 2009; 18: 213-221 Year: 2009 The future of disease monitoring and management: the homework for clinical researchers Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 COPD and CHF Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 795-798 Year: 2003